Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × cabazitaxel × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 40 Breast 5 Thoracic 3 Gastrointestinal 3 CNS 3 Head & Neck 2 Gynecologic 2 Tumor-Agnostic 1 Sarcoma 1 Endocrine 1

Conditions

Adrenocortical Carcinoma 1

Interventions

Everolimus 25 lutetium Lu 177 dotatate 21 pembrolizumab 19 Temozolomide 18 Cisplatin 14 Magnetic Resonance Spectroscopy 13 Sunitinib 12 Nivolumab 12 lenvatinib 11 cabozantinib 11 Specimen Handling 11 Capecitabine 10 Sorafenib 9 Etoposide 9 Bevacizumab 9 trametinib 7 pasireotide 7 lanreotide 7 dabrafenib 7 Paclitaxel 7 Octreotide 7 Ipilimumab 7 Carboplatin 7 pazopanib 6 Irinotecan 6 gallium Ga 68 dotatate 5 Mitotane 5 Injections 5 Fluorodeoxyglucose F18 5 surufatinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03257891 2018-04-11

CabACC

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 2 Unknown

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡